ZNF584
gene geneOn this page
Also known as FLJ39899
Summary
ZNF584 (zinc finger protein 584, HGNC:27318) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 584 (Q8IVC4). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 201514 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_173548
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27318 |
| Approved symbol | ZNF584 |
| Name | zinc finger protein 584 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ39899 |
| Ensembl gene | ENSG00000171574 |
| Ensembl biotype | protein_coding |
| Entrez | 201514 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 6 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000306910, ENST00000322834, ENST00000593920, ENST00000594993, ENST00000596281, ENST00000596921, ENST00000598901, ENST00000599145, ENST00000599238, ENST00000703727, ENST00000703728, ENST00000703729
RefSeq mRNA: 3 — MANE Select: NM_173548
NM_001318002, NM_001363680, NM_173548
CCDS: CCDS12979, CCDS82414, CCDS86814
Canonical transcript exons
ENST00000306910 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001169792 | 58409941 | 58410091 |
| ENSE00003119974 | 58408649 | 58409165 |
| ENSE00003547209 | 58415524 | 58415646 |
| ENSE00003574851 | 58416811 | 58418327 |
Expression profiles
Bgee: expression breadth ubiquitous, 202 present calls, max score 84.81.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.1079 / max 81.2498, expressed in 1673 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177844 | 3.0584 | 1454 |
| 177845 | 1.9059 | 1193 |
| 177843 | 1.1436 | 526 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 84.81 | gold quality |
| secondary oocyte | CL:0000655 | 83.11 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.84 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.07 | gold quality |
| cortical plate | UBERON:0005343 | 79.72 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 79.66 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 79.60 | gold quality |
| muscle of leg | UBERON:0001383 | 79.52 | gold quality |
| right atrium auricular region | UBERON:0006631 | 79.28 | gold quality |
| heart left ventricle | UBERON:0002084 | 79.25 | gold quality |
| cardiac ventricle | UBERON:0002082 | 78.96 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.86 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.76 | gold quality |
| ventricular zone | UBERON:0003053 | 78.75 | gold quality |
| cardiac atrium | UBERON:0002081 | 78.71 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 78.24 | gold quality |
| right uterine tube | UBERON:0001302 | 78.21 | gold quality |
| heart | UBERON:0000948 | 78.18 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.10 | gold quality |
| left adrenal gland | UBERON:0001234 | 78.02 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.94 | gold quality |
| skin of abdomen | UBERON:0001416 | 77.88 | gold quality |
| skin of leg | UBERON:0001511 | 77.70 | gold quality |
| upper arm skin | UBERON:0004263 | 77.58 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 77.54 | gold quality |
| lower esophagus | UBERON:0013473 | 77.51 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.48 | gold quality |
| adrenal cortex | UBERON:0001235 | 77.43 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 77.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.94 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
25 targeting ZNF584, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-10400-3P | 97.29 | 64.66 | 597 |
| HSA-MIR-4674 | 97.29 | 64.62 | 597 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
| HSA-MIR-4433A-5P | 96.79 | 65.01 | 599 |
| HSA-MIR-3165 | 96.18 | 66.22 | 473 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
| HSA-MIR-6735-3P | 96.10 | 63.81 | 600 |
| HSA-MIR-3675-5P | 95.90 | 65.80 | 474 |
| HSA-MIR-659-5P | 95.36 | 65.00 | 300 |
| HSA-MIR-6890-5P | 92.89 | 65.83 | 442 |
Literature-anchored findings (GeneRIF, showing 1)
- total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers (PMID:28349825)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 584 — Q8IVC4 (reviewed: Q8IVC4)
All UniProt accessions (6): Q8IVC4, F6W0P0, M0QZA3, M0R0A3, M0R2W6, M0R3F5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001304931, NP_001350609, NP_775819* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13894
UniProt features (16 total): zinc finger region 8, region of interest 2, compositionally biased region 2, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IVC4-F1 | 65.17 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 75 (showing top):
ROVERSI_GLIOMA_COPY_NUMBER_UP, DOUGLAS_BMI1_TARGETS_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ATF6_TARGET_GENES, BARX1_TARGET_GENES, CEBPZ_TARGET_GENES, CIITA_TARGET_GENES, E2F2_TARGET_GENES, FOXJ2_TARGET_GENES, HOXB4_TARGET_GENES, HOXB6_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, SUPT16H_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
318 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF584 | RNF225 | M0QZC1 | 645 |
| ZNF584 | SLC27A5 | Q9Y2P5 | 568 |
| ZNF584 | FBXL17 | Q9UF56 | 501 |
| ZNF584 | GNB5 | O14775 | 482 |
| ZNF584 | EXOC4 | Q96A65 | 481 |
| ZNF584 | LRRC61 | Q9BV99 | 479 |
| ZNF584 | MAP10 | Q9P2G4 | 479 |
| ZNF584 | FUT8 | Q9BYC5 | 475 |
| ZNF584 | TSNARE1 | Q96NA8 | 449 |
| ZNF584 | PDE4D | Q08499 | 448 |
| ZNF584 | REEP3 | Q6NUK4 | 438 |
| ZNF584 | SGCZ | Q96LD1 | 438 |
| ZNF584 | SLC18B1 | Q6NT16 | 433 |
| ZNF584 | CLCC1 | Q96S66 | 430 |
| ZNF584 | NRXN1 | Q9ULB1 | 426 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LZTR1 | ZNF584 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF584 | LRP4 | psi-mi:“MI:0914”(association) | 0.350 |
| APP | ZNF584 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): ZNF584 (Synthetic Lethality), ZNF584 (Affinity Capture-RNA), RNF41 (Affinity Capture-MS), MPP1 (Affinity Capture-MS), LRP4 (Affinity Capture-MS), CBX5 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), SOGA1 (Affinity Capture-MS), ZNF584 (Affinity Capture-MS), ZNF584 (Two-hybrid), ZNF584 (Affinity Capture-RNA), ZNF584 (Two-hybrid)
ESM2 similar proteins: A0JPL0, A1L1L7, A3KN32, A3KN36, D3ZVT0, O43296, P08042, P16373, P17023, P17031, P52738, P85977, Q02975, Q12901, Q14592, Q29RZ4, Q3KNS6, Q4R6J4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBY9, Q5T5D7, Q61751, Q61967, Q62396, Q6GQR8, Q6ZNG0, Q6ZS27, Q7Z398, Q8BI99, Q8BIQ3, Q8IVC4, Q8IZ26, Q8N988, Q8N9Z0, Q8NDP4
Diamond homologs: A0JPL0, A2VDP4, A3KN32, A6NFI3, A6NM28, A6QLU5, B2RXC5, B4DU55, O43296, O60765, O75290, O75467, P10072, P15622, P17014, P17023, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P52736, P52738, Q02975, Q06730, Q06732, Q14590, Q14929, Q16587, Q29RZ4, Q2TL60, Q3KNS6, Q3KQV3, Q49AA0, Q4R8H9, Q4V8A8, Q4V8E9, Q5FWF6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1035 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58416809:AGAT:A | acceptor_gain | 1.0000 |
| 19:58416810:GATG:G | acceptor_gain | 1.0000 |
| 19:58408693:G:GT | donor_gain | 0.9900 |
| 19:58410088:CTGGG:C | donor_loss | 0.9900 |
| 19:58410089:TGGG:T | donor_loss | 0.9900 |
| 19:58410090:GG:G | donor_gain | 0.9900 |
| 19:58410090:GGGTA:G | donor_loss | 0.9900 |
| 19:58410091:GG:G | donor_gain | 0.9900 |
| 19:58410091:GGTAA:G | donor_loss | 0.9900 |
| 19:58410092:GTA:G | donor_loss | 0.9900 |
| 19:58410093:TAAGT:T | donor_loss | 0.9900 |
| 19:58415631:A:T | donor_gain | 0.9900 |
| 19:58415644:TTGGT:T | donor_loss | 0.9900 |
| 19:58415645:TGG:T | donor_loss | 0.9900 |
| 19:58415646:GGT:G | donor_loss | 0.9900 |
| 19:58415647:G:C | donor_loss | 0.9900 |
| 19:58415647:G:GG | donor_gain | 0.9900 |
| 19:58415648:TAA:T | donor_loss | 0.9900 |
| 19:58416806:TTCA:T | acceptor_loss | 0.9900 |
| 19:58416807:TCAG:T | acceptor_loss | 0.9900 |
| 19:58416808:CAGA:C | acceptor_loss | 0.9900 |
| 19:58416809:A:C | acceptor_loss | 0.9900 |
| 19:58409164:AGG:A | donor_loss | 0.9800 |
| 19:58409165:GGT:G | donor_loss | 0.9800 |
| 19:58409167:T:A | donor_loss | 0.9800 |
| 19:58410088:CTGG:C | donor_gain | 0.9800 |
| 19:58410092:G:GG | donor_gain | 0.9800 |
| 19:58410094:AA:A | donor_loss | 0.9800 |
| 19:58415519:CGCAG:C | acceptor_loss | 0.9800 |
| 19:58415520:GCAGG:G | acceptor_loss | 0.9800 |
AlphaMissense
2798 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58417269:T:C | F251L | 0.998 |
| 19:58417271:C:A | F251L | 0.998 |
| 19:58417271:C:G | F251L | 0.998 |
| 19:58417353:T:C | F279L | 0.998 |
| 19:58417355:C:A | F279L | 0.998 |
| 19:58417355:C:G | F279L | 0.998 |
| 19:58417605:T:C | F363L | 0.998 |
| 19:58417607:C:A | F363L | 0.998 |
| 19:58417607:C:G | F363L | 0.998 |
| 19:58417185:T:C | F223L | 0.997 |
| 19:58417187:C:A | F223L | 0.997 |
| 19:58417187:C:G | F223L | 0.997 |
| 19:58417689:T:C | F391L | 0.996 |
| 19:58417691:C:A | F391L | 0.996 |
| 19:58417691:C:G | F391L | 0.996 |
| 19:58417276:G:C | R253P | 0.995 |
| 19:58417296:C:G | H260D | 0.994 |
| 19:58417300:A:C | Q261P | 0.994 |
| 19:58417464:C:G | H316D | 0.994 |
| 19:58417550:C:A | H344Q | 0.994 |
| 19:58417550:C:G | H344Q | 0.994 |
| 19:58417214:C:A | H232Q | 0.993 |
| 19:58417214:C:G | H232Q | 0.993 |
| 19:58417296:C:A | H260N | 0.993 |
| 19:58417298:C:A | H260Q | 0.993 |
| 19:58417298:C:G | H260Q | 0.993 |
| 19:58417464:C:A | H316N | 0.993 |
| 19:58417540:T:C | L341P | 0.993 |
| 19:58417562:C:A | H348Q | 0.993 |
| 19:58417562:C:G | H348Q | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000105963 (19:58401277 G>A,T), RS1000128585 (19:58418548 C>T), RS1000200275 (19:58401982 T>G), RS1000334326 (19:58404679 C>T), RS1000548299 (19:58414293 T>C,G), RS1000639841 (19:58410423 CTG>C), RS1000672793 (19:58404829 A>C), RS1000672879 (19:58406060 A>G), RS1000699732 (19:58409240 G>A), RS1000906462 (19:58411018 C>T), RS1001109400 (19:58408330 G>C), RS1001207276 (19:58411223 T>C), RS1001262655 (19:58411621 T>A), RS1001425981 (19:58406531 G>A,T), RS1001537580 (19:58414647 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004058_2 | Uric acid clearance | 1.000000e-06 |
| GCST90002402_577 | Platelet count | 1.000000e-20 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Tobacco Smoke Pollution | decreases expression, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Methotrexate | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HA04 | K562 eGFP-ZNF584 | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.